Intech Investment Management LLC Inozyme Pharma, Inc. Transaction History

Intech Investment Management LLC

  • $10.8 Billion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025
SELL
$0.82 - $4.0 $5,604 - $27,340
-6,835 Reduced 17.2%
32,892 $131,000
Q1 2025

May 20, 2025
BUY
$0.91 - $3.07 $13,777 - $46,479
15,140 Added 61.58%
39,727 $36,000
Q4 2024

Feb 10, 2025
BUY
$2.48 - $5.54 $60,975 - $136,211
24,587 New
24,587 $68,000

Others Institutions Holding INZY

# of Institutions
4
Shares Held
4.86M
Call Options Held
0
Put Options Held
0
View Full List

About Inozyme Pharma, Inc.

INZY Quotes by TradingView
  • Ticker INZY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,145,700
  • Market Cap $161M
  • Description
  • Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...
More about INZY
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email